Mohamed Elsayed Email & Phone Number
Chief Executive Officer @ Nucleic Acid Therapeutics Initiative (NATi)
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mohamed Elsayed Location
- Boston, MA, US
Mohamed Elsayed Work
- 2025 -now Chief Executive Officer @
- now Chief Scientific Officer @
- 2022 -2024 Executive Vice President and Chief Technology Officer @
- 2018 -2022 Vice President | Biotechnology Research and Development @ Eli Lilly and Company
- 2016 -2018 Executive Director | Biotechnology Research and Development @ Eli Lilly and Company
- 2006 -2016 Professor of Biomedical Engineering | Head of Cellular Engineering and Nano-Therapeutics Laboratory @
- 2010 -2015 Technical and Strategy Advisor @
- now Technical and Strategic Advisor @
Mohamed Elsayed Education
- University of Maryland, Baltimore (UMB)
Doctor of Philosophy (Ph.D.) (Pharmaceutical Sciences)
- University of Washington
Postdoctoral Fellow & Group Leader (Bioengineering and Biomedical Engineering)
- University of Mississippi
Graduate Teaching & Research Assistant (Pharmaceutics)
- Cairo University
Bachelor of Pharmacy - BPharm (Pharmacy, Pharmaceutical Sciences, and Administration)
Mohamed Elsayed Skills
- Technology Roadmapping
- Biopharmaceuticals
- Biotechnology
- Budget Development
- Building C-Level Relationships
- C-Level Leadership
- Competitive Analysis
- Conference Speaking
- Coaching & Mentoring
- Collaborative Leadership
- Cross-team Collaboration
- Continuous Improvement
- CRO Management
- Cross-functional Team Leadership
- Change Management
- Clinical Trials
- Culture Development
- Diversity Program Development
- Drug Development
- Due Diligence
- Fundraising
- Federal Grants Management
- Global R&D Organizations
- Grantsmanship
- Global Strategy
- Investigational New Drug Application (IND)
- Interdisciplinary Collaboration
- Leadership of cross-functional teams
- Multi-disciplinary Teams
- Matrix Leadership
- Nanotechnology
- Operations Management
- Operational Strategy
- Pharmaceutical Research
- Portfolio Optimization
- Project Management
- Presentation Development
- Public Speaking
- Publications
- Risk Management
- Regulatory Documentation
- Strategic Initiatives
- Strategic Partnerships
- Talent Development
- Team Building
- Vision and Strategic Direction
Mohamed Elsayed Summary
- Mohamed Elsayed, based in Boston, MA, US, is currently a Chief Executive Officer at Nucleic Acid Therapeutics Initiative (NATi). Mohamed Elsayed brings experience from previous roles at Nucleic Acid Therapeutics Initiative (NATi), RVAC Medicines and Eli Lilly and Company. Mohamed Elsayed holds a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences @ University of Maryland, Baltimore (UMB). With a robust skill set that includes Technology Roadmapping, Biopharmaceuticals, Biotechnology, Budget Development, Building C-Level Relationships and more. Mohamed Elsayed has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Mohamed Elsayed?
Find contact details for 700 million professionals.
Others Named Mohamed Elsayed
Mohamed Elsayed
Director, Emerging Markets Portfolio Marketing Lead Precision Medicine
Cairo, Cairo Governorate, EG
Mohamed Elsayed
Chief Financial Officer
Saudi Arabia
Mohamed Elsayed
Chief Executive Officer
Boston, MA, US
Top Nucleic Acid Therapeutics Initiative (NATi) Employees
Arpan Mukherjee
mRNA DS Lead and Sr. Scientist II
Chapel Hill, NC, US
Kathy Rivett-Carnac
Ag Deputy Director
Singapore
Mohamed Elsayed
Chief Executive Officer
Boston, MA, US
Vanessa Tay
Lead Program Manager
Singapore
Nani Djunaidi
Project Manager
Singapore
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co